Method and composition for treating ocular hypertension and glaucoma

Details for Australian Patent Application No. 2009252210 (hide)

Owner SANTEN PHARMACEUTICAL CO., LTD. ASAHI GLASS CO., LTD.

Inventors Pellinen, Pertti; Lehmussaari, Kari; Oksala, Olli; Reunamaki, Timo

Agent Collison & Co

Pub. Number AU-A-2009252210

PCT Pub. Number WO2009/145356

Priority 08397513.6 30.05.08 EP

Filing date 28 May 2009

Wipo publication date 3 December 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/5575 (2006.01)

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/145356 Priority application(s): WO2009/145356

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009252214-Benzene or thiophene derivative and use thereof as VAP-1 inhibitor

2009252166-Heterocyclic derivatives